Internal Medicine, Medical Oncology · Reno, NV
NPI
1306878228
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
75 Pringle Way Ste 801
Reno, NV, 89502
Phone (775) 982-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
383 services
Medicare patients, 2024
154
Average age 73
Drug cost, 2024
$1.4M
786 prescriptions
Company payments, 2025
$137K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lee S Schwartzberg was code 99214 (office e&m - established), 208 times for 93 patients. In total Lee S Schwartzberg billed 383 services in 11 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 208 | 93 | $67.60 | $14K |
| 99213 Office E&M - Established | Facility | 76 | 66 | $43.60 | $3,313 |
| 99204 Office E&M - New | Facility | 45 | 45 | $96.45 | $4,340 |
| 99215 Office E&M - Established | Facility | 18 | 15 | $97.11 | $1,748 |
| 99205 Office E&M - New | Facility | 15 | 15 | $129.36 | $1,940 |
By year: 2022 $27K for 359 services; 2023 $33K for 437 services; 2024 $27K for 383 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 21 | 20 | $2.99 | $62.79 |
Medicare prescription drug claims, 2024
In 2024, the drug Lee S Schwartzberg prescribed most often to Medicare patients was Anastrozole, with 233 prescriptions and refills. In total Lee S Schwartzberg wrote 786 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 233 | 632 | 76 | $6,804 |
| Tamoxifen Citrate Generic | 115 | 270 | 33 | $3,496 |
| Letrozole Generic | 71 | 130 | 17 | $1,615 |
| Dexamethasone Generic | 33 | 35 | 13 | $260 |
| Ondansetron Hcl Generic | 31 | 31 | 23 | $122 |
| Vitrakvi Larotrectinib Sulfate | 29 | 29 | Under 11 | $883K |
| Prochlorperazine Maleate Generic | 25 | 25 | 21 | $285 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 23 | 23 | Under 11 | $295 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 20 | 31 | Under 11 | $438 |
| Levothyroxine Sodium Generic | 13 | 18 | Under 11 | $46.27 |
| Etodolac Generic | 13 | 13 | Under 11 | $531 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 12 | 12 | Under 11 | $149 |
| Gabapentin Generic | 11 | 11 | Under 11 | $83.37 |
| Ibrance Palbociclib | 11 | 11 | Under 11 | $193K |
Brand drugs: 73 claims; generic drugs: 713 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lee S Schwartzberg $137K ($137K in general payments such as food, travel and fees and $125 for research) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $51K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 35 | $51K |
| Cornerstone Specialty Network LLC | 2 | $37K |
| Daiichi Sankyo Inc. 4568.T | 26 | $23K |
| Napo Pharmaceuticals Inc | 9 | $11K |
| Merck Sharp & Dohme LLC MRK | 9 | $9,623 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $3,234 |
| Stemline Therapeutics Inc. | 2 | $1,581 |
| Gilead Sciences, Inc. GILD | 1 | $730 |
| Hoffmann-La Roche Limited ROG.SW | 1 | $125 |
| Incyte Corporation INCY | 2 | $53.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.